Xtant Medical Holdings, Inc. Announces Expiration of Rights Offering
19 juin 2018 08h00 HE
|
Xtant Medical Holdings, Inc.
BELGRADE, MT, June 19, 2018 (GLOBE NEWSWIRE) -- XtantTM Medical Holdings, Inc. (NYSE American: XTNT) announces that the subscription period for its previously announced rights offering (the...
Xtant Medical Announces Compliance with NYSE American
15 févr. 2018 16h45 HE
|
Xtant Medical Holdings, Inc.
Reports Pro Forma Stockholders’ Equity of approximately $47.4M as of 2/15/18Xtant has regained compliance with the NYSE American listing standards BELGRADE, Mont., Feb. 15, 2018 (GLOBE NEWSWIRE) --...
Xtant Medical Announces Exchange of Outstanding Convertible Notes and Closing of Private Placement
14 févr. 2018 16h30 HE
|
Xtant Medical Holdings, Inc.
Exchange of $70.238M (plus interest) of convertible notes into 10,401,309 shares of common stock at $7.20 per share.$6.809M Private Placement representing 945,819 shares of common stock at $7.20 per...
Xtant Medical Announces Results of Special Meeting of Stockholders
13 févr. 2018 14h55 HE
|
Xtant Medical Holdings, Inc.
Approval of the issuance of new shares of common stock, as required by the NYSE American.Approval of an amendment to its certificate of incorporation, enabling its previously announced 1:12 reverse...
Xtant Medical Enters into Restructuring and Exchange Agreement with All Holders of Outstanding Convertible Notes
18 janv. 2018 08h30 HE
|
Xtant Medical Holdings, Inc.
Conversion of $1.627M (plus interest) of convertible notes into common stockExchange of $70.238M (plus interest) of convertible notes into common stockUpon stockholder approval, amendment of...
Xtant Medical Reports Third Quarter 2017 Financial Results
21 nov. 2017 15h39 HE
|
Xtant Medical Holdings, Inc.
Company restructuring efforts continue to gain traction towards profitability Third Quarter 2017 Highlights Reported third quarter 2017 revenue of $19.8 million compared to $23.1 million reported...
Xtant Medical Postpones Release of Third Quarter 2017 Financial Results
09 nov. 2017 07h30 HE
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, announced...
Xtant Medical Enters into a Distribution Agreement with curasan, Inc. Bringing Matriform™ to Market
01 nov. 2017 16h30 HE
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, today...
Xtant Medical to Announce Third Quarter 2017 Results on Wednesday, November 8th
27 oct. 2017 12h04 HE
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Oct. 27, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, today...
Xtant Medical to Feature Product Portfolio at the 2017 North American Spine Society Annual Meeting
25 oct. 2017 10h12 HE
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, announced it...